A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Neuroscience. 2019 Sep 1;415:184-200. doi: 10.1016/j.neuroscience.2019.07.040. Epub 2019 Jul 27.
Sushi repeat-containing protein X-linked 2 (SRPX2) is a novel hypothalamic protein and a ligand of the urokinase-type plasminogen activator receptor (uPAR), which is essential for proteolysis of extracellular matrix and tissue remodeling after an insult to the brain. However, little is known about regulation of SRPX2. Our objective was to investigate if SRPX2 expression is altered by (i) the deficiency of uPAR or uPA (urokinase-type plasminogen activator), and (ii) traumatic brain injury (TBI). SRPX2 expression was assessed in wild type (Wt), Plaur (uPAR-deficient), and Plau (uPA-deficient) mice, with and without controlled cortical impact injury (CCI). The number of SRPX2+ neurons in hypothalamus was comparable to that in Wt littermates in Plaur (2985 ± 138 vs. 2890 ± 92, p > 0.05) and Plau mice (2180 ± 232 vs. 2027 ± 77, p > 0.05). The number of hypothalamic SRPX2+ neurons in the Wt-CCI group was comparable to that in controls (3645 ± 288 vs. 3385 ± 192, p > 0.05). Hypothalamic, hippocampal and thalamic Srpx2 gene expression was unaltered after TBI. However, at 4 days post-TBI Srpx2 gene expression was upregulated in the perilesional cortex of Plau-CCI mice up to 123% of that in the sham group (p < 0.05). Unsupervised hierarchical clustering using SRPX2 expression did not identify genotype or injury-specific clusters. Our data demonstrate that SRPX2 expression in the hypothalamus is resistant to genetic deficiencies in the urokinase-system or to the hypothalamus-affecting TBI. The contribution of elevated Srpx2 gene expression in perilesional cortex to post-TBI recovery process, however, requires further exploration.
X 连锁重复 sushi 蛋白 2(SRPX2)是一种新型的下丘脑蛋白,也是尿激酶型纤溶酶原激活物受体(uPAR)的配体,在脑损伤后对细胞外基质的蛋白水解和组织重塑至关重要。然而,对于 SRPX2 的调控机制知之甚少。我们的目的是研究 uPAR 或 uPA(尿激酶型纤溶酶原激活物)缺乏以及创伤性脑损伤(TBI)是否会改变 SRPX2 的表达。在野生型(Wt)、Plaur(uPAR 缺陷型)和 Plau(uPA 缺陷型)小鼠中,评估了有和没有皮质控制撞击伤(CCI)的情况下,SRPX2 表达情况。下丘脑的 SRPX2+神经元数量与 Plaur(2985±138 比 2890±92,p>0.05)和 Plau 小鼠(2180±232 比 2027±77,p>0.05)中的 Wt 同窝仔鼠相当。Wt-CCI 组下丘脑的 SRPX2+神经元数量与对照组相当(3645±288 比 3385±192,p>0.05)。TBI 后,下丘脑、海马和丘脑的 Srpx2 基因表达没有改变。然而,在 TBI 后 4 天,Plau-CCI 小鼠的损伤皮层周围的 Srpx2 基因表达上调至对照组的 123%(p<0.05)。使用 SRPX2 表达进行无监督层次聚类没有鉴定出基因型或损伤特异性聚类。我们的数据表明,u 激酶系统的基因缺失或影响下丘脑的 TBI 均不会改变下丘脑的 SRPX2 表达。然而,损伤皮层周围升高的 Srpx2 基因表达对 TBI 后恢复过程的贡献需要进一步探索。